172 related articles for article (PubMed ID: 7905266)
61. Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16.
Sugawara I; Kataoka I; Morishita Y; Hamada H; Tsuruo T; Itoyama S; Mori S
Cancer Res; 1988 Apr; 48(7):1926-9. PubMed ID: 2894894
[TBL] [Abstract][Full Text] [Related]
62. A simple fluorometric method to discriminate adriamycin-resistant subline from adriamycin-sensitive parental P388 murine leukemia cell line.
Dekker K; Kojima N; Yamamoto S; Tatsumi K; Mino M; Yagi K
Biochem Int; 1987 Jun; 14(6):997-1001. PubMed ID: 3453100
[TBL] [Abstract][Full Text] [Related]
63. Multidrug resistance gene transcript level, and P-glycoprotein expression in paediatric malignant mesenchymal tumours.
McDowell H; Peuchmaur M; Dominici C; Flamant F
Anticancer Res; 1993; 13(5C):1863-6. PubMed ID: 7903523
[TBL] [Abstract][Full Text] [Related]
64. Modulation of drug resistance in a daunorubicin resistant subline with oligonucleoside methylphosphonates.
Vasanthakumar G; Ahmed NK
Cancer Commun; 1989; 1(4):225-32. PubMed ID: 2576974
[TBL] [Abstract][Full Text] [Related]
65. Effect of homoharringtonine on the viability of murine leukemia P388 cells resistant to either adriamycin, vincristine, or 1-beta-D-arabinofuranosylcytosine.
Wilkoff LJ; Dulmadge DA; Laster WR; Griswold DP
Cancer Chemother Pharmacol; 1989; 23(3):145-50. PubMed ID: 2924372
[TBL] [Abstract][Full Text] [Related]
66. Kinetic analysis of active efflux of vincristine from multidrug-resistant P388 leukemia cells.
Inaba M; Watanabe T; Sugiyama Y
Jpn J Cancer Res; 1987 Apr; 78(4):397-404. PubMed ID: 3108219
[TBL] [Abstract][Full Text] [Related]
67. P-glycoprotein expression and modulation of cell-membrane morphology in adriamycin-resistant P388 leukemia cells.
Radel S; Fredericks W; Mayhew E; Baker R
Cancer Chemother Pharmacol; 1990; 25(4):241-6. PubMed ID: 1967228
[TBL] [Abstract][Full Text] [Related]
68. Detection of murine S180 cells expressing a multidrug resistance phenotype using different in vitro test systems and a monoclonal antibody.
Volm M; Efferth T; Günther A; Lathan B
Arzneimittelforschung; 1987 Jul; 37(7):862-7. PubMed ID: 3314882
[TBL] [Abstract][Full Text] [Related]
69. Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance.
Scheper RJ; Broxterman HJ; Scheffer GL; Kaaijk P; Dalton WS; van Heijningen TH; van Kalken CK; Slovak ML; de Vries EG; van der Valk P
Cancer Res; 1993 Apr; 53(7):1475-9. PubMed ID: 7680954
[TBL] [Abstract][Full Text] [Related]
70. Differences in lipid composition of doxorubicin-sensitive and -resistant P388 cells.
Ramu A; Glaubiger D; Weintraub H
Cancer Treat Rep; 1984 Apr; 68(4):637-41. PubMed ID: 6713419
[TBL] [Abstract][Full Text] [Related]
71. Is multidrug resistance relevant in breast cancer?
Wishart GC; Kaye SB
Eur J Surg Oncol; 1991 Oct; 17(5):485-8. PubMed ID: 1682166
[TBL] [Abstract][Full Text] [Related]
72. P-glycoprotein expression in multiple myeloma.
Carulli G; Petrini M; Marini A; Ambrogi F; Ucci G; Riccardi A; Luoni R; Grassi B
Haematologica; 1990; 75(3):288-90. PubMed ID: 1977668
[TBL] [Abstract][Full Text] [Related]
73. Differential growth inhibition of isoquinolinesulfonamides H-8 and H-7 towards multidrug-resistant P388 murine leukaemia cells.
Ido M; Nagao Y; Higashigawa M; Shibata T; Taniguchi K; Hamazaki M; Sakurai M
Br J Cancer; 1991 Dec; 64(6):1103-7. PubMed ID: 1684908
[TBL] [Abstract][Full Text] [Related]
74. Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells.
Ganapathi R; Reiter W; Krishan A
J Natl Cancer Inst; 1982 Jun; 68(6):1027-32. PubMed ID: 6953267
[TBL] [Abstract][Full Text] [Related]
75. [The expression of P-glycoprotein in leukemia P388 cells with induced doxorubicin resistance].
Sukhanov VA; D'iakov VL; Lalaev VV; Iakh'iaev AV; Voronkova IM; Donenko FV; Borovkova NB; Moroz LV
Biull Eksp Biol Med; 1991 Mar; 111(3):290-1. PubMed ID: 1675897
[TBL] [Abstract][Full Text] [Related]
76. Monoclonal antibody C219 detection of the multidrug-resistant protein P-glycoprotein in routinely processed tissues: a study of 36 cases of ovarian carcinoma.
Rutledge ML; Robey-Cafferty SS; Silva EG; Bruner JM
Mod Pathol; 1990 May; 3(3):298-301. PubMed ID: 1972985
[TBL] [Abstract][Full Text] [Related]
77. P-glycoprotein gene amplification and expression in multidrug-resistant murine P388 and B16 cell lines.
Capranico G; De Isabella P; Castelli C; Supino R; Parmiani G; Zunino F
Br J Cancer; 1989 May; 59(5):682-5. PubMed ID: 2567607
[TBL] [Abstract][Full Text] [Related]
78. Detection of P-glycoprotein in solid tumors by flow cytometry.
Fujii H; Tanigawa N; Muraoka R; Shimomatsuya T; Tanaka T
Anticancer Res; 1993; 13(6A):2171-5. PubMed ID: 7905253
[TBL] [Abstract][Full Text] [Related]
79. Adriamycin resistance in HL60 cells and accompanying modification of a surface membrane protein contained in drug-sensitive cells.
Marsh W; Center MS
Cancer Res; 1987 Oct; 47(19):5080-6. PubMed ID: 3621192
[TBL] [Abstract][Full Text] [Related]
80. Decreased sensitivity of multidrug-resistant tumor cells to cisplatin is correlated with sorcin gene co-amplification.
Demidova NS; Ilyinskaya GV; Shiryaeva OA; Chernova OB; Goncharova SA; Kopnin BP
Neoplasma; 1995; 42(4):195-201. PubMed ID: 7659186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
